ATE118814T1 - Verfahren zur herstellung von human-human- hybridomen, die herstellung monoklonaler bzw. polyklonaler antikörper davon und therapeutische verwendung davon. - Google Patents

Verfahren zur herstellung von human-human- hybridomen, die herstellung monoklonaler bzw. polyklonaler antikörper davon und therapeutische verwendung davon.

Info

Publication number
ATE118814T1
ATE118814T1 AT89117479T AT89117479T ATE118814T1 AT E118814 T1 ATE118814 T1 AT E118814T1 AT 89117479 T AT89117479 T AT 89117479T AT 89117479 T AT89117479 T AT 89117479T AT E118814 T1 ATE118814 T1 AT E118814T1
Authority
AT
Austria
Prior art keywords
adenocarcinoma
human
carcinoma
hybridomas
monoclonal
Prior art date
Application number
AT89117479T
Other languages
English (en)
Inventor
Kenneth Alonso
Original Assignee
Kenneth Alonso
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kenneth Alonso filed Critical Kenneth Alonso
Application granted granted Critical
Publication of ATE118814T1 publication Critical patent/ATE118814T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT89117479T 1988-09-23 1989-09-21 Verfahren zur herstellung von human-human- hybridomen, die herstellung monoklonaler bzw. polyklonaler antikörper davon und therapeutische verwendung davon. ATE118814T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24808288A 1988-09-23 1988-09-23

Publications (1)

Publication Number Publication Date
ATE118814T1 true ATE118814T1 (de) 1995-03-15

Family

ID=22937601

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89117479T ATE118814T1 (de) 1988-09-23 1989-09-21 Verfahren zur herstellung von human-human- hybridomen, die herstellung monoklonaler bzw. polyklonaler antikörper davon und therapeutische verwendung davon.

Country Status (5)

Country Link
EP (1) EP0363703B1 (de)
JP (1) JP3212987B2 (de)
AT (1) ATE118814T1 (de)
CA (1) CA1341552C (de)
DE (1) DE68921282T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
CA2044421C (en) * 1990-11-27 2005-06-21 Thomas Hyatt Duffy Squamous cell carcinoma-like immunoreactive antigen from human female urine
US6593255B1 (en) 1998-03-03 2003-07-15 Ppg Industries Ohio, Inc. Impregnated glass fiber strands and products including the same
US6419981B1 (en) 1998-03-03 2002-07-16 Ppg Industries Ohio, Inc. Impregnated glass fiber strands and products including the same
US6949289B1 (en) 1998-03-03 2005-09-27 Ppg Industries Ohio, Inc. Impregnated glass fiber strands and products including the same
US8105690B2 (en) 1998-03-03 2012-01-31 Ppg Industries Ohio, Inc Fiber product coated with particles to adjust the friction of the coating and the interfilament bonding
US8062746B2 (en) 2003-03-10 2011-11-22 Ppg Industries, Inc. Resin compatible yarn binder and uses thereof
DE10352977A1 (de) * 2003-11-13 2005-06-09 Müller-Hermelink, Hans Konrad, Prof. Dr. Muriner anti Idiotyp-Antikörpers oder anti Idiotyp-Antikörper aus der Ratte des humanen monoklonalen SC-1 Antikörpers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU530649B2 (en) * 1981-01-28 1983-07-21 Coats Patons Plc Method of manufacturing monoclonal antibodies and capable of manufacturing such antibodies
US4613576A (en) * 1983-03-09 1986-09-23 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cancer cells
US5106746A (en) * 1985-05-22 1992-04-21 E. I. Du Pont De Nemours And Company Process for the in vitro immunization of human splenocytes against tumor associated antigens

Also Published As

Publication number Publication date
DE68921282T2 (de) 1995-06-22
CA1341552C (en) 2007-10-02
JP3212987B2 (ja) 2001-09-25
JPH02195876A (ja) 1990-08-02
EP0363703A1 (de) 1990-04-18
EP0363703B1 (de) 1995-02-22
DE68921282D1 (de) 1995-03-30

Similar Documents

Publication Publication Date Title
DE3751585D1 (de) Hybridome, die monoklonale Antikörper gegen neue Mucin-Epitope produzieren.
EP0220858A3 (en) Monoclonal anti-human breast cancer antibodies, corresponding hybridomas, the production and use thereof
ES8705975A1 (es) Un metodo de deteccion o localizacion de celulas de carcinoma humano.
FI863375L (fi) Menetelmä monoklonaalisten vasta-aineiden valmistamiseksi ihmisen ei-pienisoluisia keuhkosyöpäkasvaimia varten
EP0586002A3 (en) Monoclonal antibodies recognizing the epidermal growth factor receptor, cells and methods for their production and compositions containing them
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
NL300350I1 (nl) Geneesmiddelen met monoclonale antilichamen, die specifiek zijn voor de menselijk epidermale groeifactorreceptor
FI963393A0 (fi) Syöpäolosuhteiden määritys MAGE-geeni-ilmennyksellä
IT8319234A0 (it) Procedimento per la produzione di anticorpi monoclonali umani.
DE3484520D1 (de) Monoklonale antikoerper gegen menschlichen dickdarmkrebs und verfahren.
ATE56046T1 (de) Monoklonale antikoerper gegen humane brustkarzinomzellen und ihre verwendung in der diagnose und therapie.
ATE118814T1 (de) Verfahren zur herstellung von human-human- hybridomen, die herstellung monoklonaler bzw. polyklonaler antikörper davon und therapeutische verwendung davon.
UA86768C2 (ru) ХИМЕРНОЕ МОНОКЛОНАЛЬНОЕ АНТИТЕЛО, ПОЛУЧЕННОЕ ИЗ МЫШИНОГО АНТИИДИОТИПИЧНОГО МОНОКЛОНАЛЬНОГО АНТИТЕЛА 1Е10, КОТОРОЕ РАСПОЗНАЕТ МЫШИНОЕ MAbР3
GR3033630T3 (en) Gene expression elements and the production of chimeric mouse-human antibodies.
ATE79038T1 (de) Anti-immuntoxine gegen menschlichen eierstockkrebs und verfahren zu deren verwendung.
DE3586216D1 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
DE3583265D1 (de) Tumortherapeutikum und verfahren zu seiner herstellung.
FI861692A0 (fi) En ny tumoerassocierad antigen.
IT1264083B1 (it) Procedimento per la produzione in piante di anticorpi ingegnerizzati, anticorpi prodotti e loro uso in diagnosi e terapia.
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
IT8319598A0 (it) Procedimento per trattare silicio allo scopo di produrre clorosilani.
EP0293262A3 (de) Monoklonale Antikörper, die menschliche Darmkrebszellen erkennen, entsprechende Hybridome, ihre Herstellung und ihre Verwendung
EP0278160A3 (de) Menschliche monoklonale Antikörper gegen Krebs, Hybridoma-Zellinien, die sie herstellen und ihre Anwendungen
TWI265811B (en) Extended type 1 chain glycosphingolipids as tumor-associated antigens

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties